CHIMERIX FDA Approval NDA 214460

NDA 214460

CHIMERIX

FDA Drug Application

Application #214460

Documents

Letter2021-06-07
Label2021-06-11

Application Sponsors

NDA 214460CHIMERIX

Marketing Status

Prescription001

Application Products

001TABLET; ORAL SUSPENSION10MG/ML0TEMBEXABRINCIDOFOVIR

FDA Submissions

TYPE 2; Type 2 - New Active IngredientORIG1AP2021-06-04PRIORITY

Submissions Property Types

ORIG1Null25

CDER Filings

CHIMERIX
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 214460
            [companyName] => CHIMERIX
            [docInserts] => ["",""]
            [products] => [{"drugName":"TEMBEXA","activeIngredients":"BRINCIDOFOVIR","strength":"10MG\/ML","dosageForm":"TABLET; ORAL SUSPENSION","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"06\/04\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 2 - New Active Ingredient","reviewPriority":"PRIORITY; Orphan","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2021\\\/214460Origs000,214461Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-06-04
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.